Use of the IL‐6R antagonist tocilizumab in hospitalized COVID‐19 patients. (20th October 2020) - Patel, K.; Gooley, T. A.; Bailey, N.; Bailey, M.; Hegerova, L.; Batchelder, A.; Holdread, H.; Dunleavy, V.; Downey, T.; Frisvold, J.; Megrath, S.; Pagarigan, K.; et al.